Answer:
For question 1, the correct answer is A. The treatment of viral-associated lymphadenopathy is primarily supportive, with a focus on managing symptoms and preventing complications. Specific antiviral therapies are generally not effective for treating viral-associated lymphadenopathy.
For question 2, the correct answer is C. The treatment of bacterial-associated lymphadenopathy typically involves administration of beta-lactamase-resistant antibiotics and drainage of purulence when fluctuation is present. Complete excision of the involved node may be necessary in some cases, but this is not the first-line treatment approach. Supportive care may be used in addition to antibiotics, particularly for managing symptoms. Rifampin and isoniazid are not typically used to treat bacterial-associated lymphadenopathy.
Step-by-step explanation: